April 1, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Product Launch

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for laboratory development test optimization PALM SPRINGS, Calif., April 1, 2019 /PRNewswire/ — MSACL US 2019 – Thermo Fisher Scientific announces the expansion of its portfolio... Read more

March 28, 2019 Clinical Research/Diagn. Liq. Handling & Robotics PR/Corporate

Quanterix Appoints Amol Chaubal as Chief Financial Officer

MARCH 28, 2019 Amol brings global pharmaceutical and diagnostic industry experience to management team to support rapid company growth and scaling  LEXINGTON, Mass. – March 28, 2019 Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has named Amol Chaubal to the position of... Read more

March 28, 2019 Clinical Research/Diagn. Mass Spectrometry Product Launch

Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry

The new standard in immune profiling for advancing translational and clinical research of immune-mediated diseases SOUTH SAN FRANCISCO, Calif., March 28, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the Maxpar® Direct™ Immune Profiling System. Setting the new standard in immune... Read more

March 25, 2019 Clinical Research/Diagn. Life Science Tools PR/Corporate

NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

SEATTLE, March 25, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 5,175,000 shares of its common stock at a price to the public of $23.00 per share pursuant to its shelf registration statement. NanoString sold 3,175,000 shares of... Read more

March 22, 2019 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics

Bruker Announces Improved Assay for Tuberculosis Diagnostics in Novel Liquid Array™ Format for Improved Multiplexing

– Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing – Novel FluoroCycler™ XT PCR system with CE-IVD mark enables new Liquid Array format NEHREN, Germany, March 22, 2019 /PRNewswire/ — In time for the World Tuberculosis (TB) Day 2019 on Sunday, March... Read more

March 21, 2019 Clinical Research/Diagn. PR/Corporate

Abcam wins the UK-China Business award

March 21, 2019- China represents an important market for us and we are thrilled to announce that Abcam has been chosen as the winner of the Cambridge Business Weekly UK-China Business Award. This new award category, which acknowledges the most effective ambassador for UK/China trade and trust over the last 12 months, has been jointly... Read more

March 19, 2019 Clinical Research/Diagn. Life Science Tools PR/Corporate

NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock

SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $23.00 per share pursuant to its shelf registration statement. NanoString will sell 2,500,000 shares of common... Read more

March 18, 2019 Clinical Research/Diagn. Life Science Tools PR/Corporate

NanoString Technologies Announces Commencement of Public Offering of Common Stock

SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its shelf registration statement. NanoString intends to offer and sell, subject to market and other conditions, 2,500,000 shares of common stock, and Clarus... Read more

March 18, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Environ, Ag./Food & Bev Informatics & Software Lab Top-10 Mass Spectrometry Molecular Spectroscopy Product Launch

Bruker Highlights New Systems and Applied Market Solutions at Pittcon

PHILADELPHIA, March 18, 2019 /PRNewswire/ — At Pittcon 2019, Bruker (Nasdaq: BRKR) this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, pharma applications, materials science research and quality control, clinical and preclinical research, and advances in scientific software solutions. Frank H. Laukien, Ph.D., Bruker’s President and CEO, commented:  “Our... Read more

March 14, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing

Walkersville, MD (USA) / Basel, Switzerland, 14 March 2019 – Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucetta™ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures. Pharmaceutical, biotechnology and academic researchers can now rely on this compact, portable and easy-to-use instrument to... Read more